Listed

Healthequity, Inc.

HQYNasdaqCIK 1428336IndustrialsFiscal year ends Jan 31

Latest reported revenue, Q2 FY2027$350.7mRevenue, Q2 FY2027, three months to 2026-07-31$350.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Report this figureThree months to Jul 31, 2026, from the 10-Q filed Aug 27, 2026.

Latest quarter: Q2 FY2027

Three months to Jul 31, 2026, against the same quarter a year earlier.

  • Revenue$350.7mRevenue, Q2 FY2027, three months to 2026-07-31$350.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Report this figure+7.6% on a year earlier
  • Gross margin73.5%Gross margin, Q2 FY2027, three months to 2026-07-31. gross profit / revenueGross profit: $258.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Revenue: $350.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Report this figure+2.2 pts on a year earlier
  • Operating margin28.1%Operating margin, Q2 FY2027, three months to 2026-07-31. operating income / revenueOperating income: $98.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Revenue: $350.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Report this figure+0.6 pts on a year earlier
  • Net margin18.7%Net margin, Q2 FY2027, three months to 2026-07-31. net income / revenueNet income: $65.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Revenue: $350.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Report this figure+0.3 pts on a year earlier
  • Diluted EPS$0.78Diluted EPS, Q2 FY2027, three months to 2026-07-31$0.78 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Report this figure+14.7% on a year earlier
  • Free cash flow$135.2mFree cash flow, Q2 FY2027, three months to 2026-07-31. operating cash flow − capital expenditureOperating cash flow: $136.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-27, accession 0001428336-26-000041. Derived: 6-month figure less the 3-month figure.Capital expenditure: $978.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-27, accession 0001428336-26-000041. Derived: 6-month figure less the 3-month figure.Report this figure+0.1% on a year earlier

Last eight quarters

Full statements
Revenue$350.7mGross margin 73.5%
Diluted EPS$0.78, Q2 FY2027
Free cash flow$135.2m, Q2 FY2027
Healthequity, Inc., key figures for the last eight quarters
Line itemUnitQ3 FY20252024-10-31Q4 FY20252025-01-31Q1 FY20262025-04-30Q2 FY20262025-07-31Q3 FY20262025-10-31Q4 FY20262026-01-31Q1 FY20272026-04-30Q2 FY20272026-07-31Shape over the periods
Revenue$m300Revenue, Q3 FY2025, three months to 2024-10-31$300.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-12-03, accession 0001428336-25-000036.Report this figure312Revenue, Q4 FY2025, three months to 2025-01-31$311.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001428336-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure331Revenue, Q1 FY2026, three months to 2025-04-30$330.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-28, accession 0001428336-26-000028.Report this figure326Revenue, Q2 FY2026, three months to 2025-07-31$325.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Report this figure322Revenue, Q3 FY2026, three months to 2025-10-31$322.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-12-03, accession 0001428336-25-000036.Report this figure335Revenue, Q4 FY2026, three months to 2026-01-31$334.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001428336-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure355Revenue, Q1 FY2027, three months to 2026-04-30$354.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-28, accession 0001428336-26-000028.Report this figure351Revenue, Q2 FY2027, three months to 2026-07-31$350.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Report this figure
Gross margin%65.6%Gross margin, Q3 FY2025, three months to 2024-10-31. gross profit / revenueGross profit: $197.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-12-03, accession 0001428336-25-000036.Revenue: $300.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-12-03, accession 0001428336-25-000036.Report this figure60.6%Gross margin, Q4 FY2025, three months to 2025-01-31. gross profit / revenueGross profit: $189.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-17, accession 0001428336-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $311.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001428336-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure67.8%Gross margin, Q1 FY2026, three months to 2025-04-30. gross profit / revenueGross profit: $224.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-28, accession 0001428336-26-000028.Revenue: $330.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-28, accession 0001428336-26-000028.Report this figure71.4%Gross margin, Q2 FY2026, three months to 2025-07-31. gross profit / revenueGross profit: $232.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Revenue: $325.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Report this figure70.8%Gross margin, Q3 FY2026, three months to 2025-10-31. gross profit / revenueGross profit: $228.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-12-03, accession 0001428336-25-000036.Revenue: $322.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-12-03, accession 0001428336-25-000036.Report this figure68.2%Gross margin, Q4 FY2026, three months to 2026-01-31. gross profit / revenueGross profit: $228.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-17, accession 0001428336-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $334.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001428336-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure72.3%Gross margin, Q1 FY2027, three months to 2026-04-30. gross profit / revenueGross profit: $256.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-28, accession 0001428336-26-000028.Revenue: $354.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-28, accession 0001428336-26-000028.Report this figure73.5%Gross margin, Q2 FY2027, three months to 2026-07-31. gross profit / revenueGross profit: $258.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Revenue: $350.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Report this figure
Operating margin%6.5%Operating margin, Q3 FY2025, three months to 2024-10-31. operating income / revenueOperating income: $19.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-12-03, accession 0001428336-25-000036.Revenue: $300.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-12-03, accession 0001428336-25-000036.Report this figure13.5%Operating margin, Q4 FY2025, three months to 2025-01-31. operating income / revenueOperating income: $42.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-17, accession 0001428336-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $311.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001428336-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure25.1%Operating margin, Q1 FY2026, three months to 2025-04-30. operating income / revenueOperating income: $83.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-28, accession 0001428336-26-000028.Revenue: $330.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-28, accession 0001428336-26-000028.Report this figure27.5%Operating margin, Q2 FY2026, three months to 2025-07-31. operating income / revenueOperating income: $89.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Revenue: $325.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Report this figure24.4%Operating margin, Q3 FY2026, three months to 2025-10-31. operating income / revenueOperating income: $78.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-12-03, accession 0001428336-25-000036.Revenue: $322.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-12-03, accession 0001428336-25-000036.Report this figure21.2%Operating margin, Q4 FY2026, three months to 2026-01-31. operating income / revenueOperating income: $71.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-17, accession 0001428336-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $334.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001428336-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure29.0%Operating margin, Q1 FY2027, three months to 2026-04-30. operating income / revenueOperating income: $103.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-28, accession 0001428336-26-000028.Revenue: $354.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-28, accession 0001428336-26-000028.Report this figure28.1%Operating margin, Q2 FY2027, three months to 2026-07-31. operating income / revenueOperating income: $98.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Revenue: $350.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Report this figure
Net margin%1.9%Net margin, Q3 FY2025, three months to 2024-10-31. net income / revenueNet income: $5.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-12-03, accession 0001428336-25-000036.Revenue: $300.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-12-03, accession 0001428336-25-000036.Report this figure8.5%Net margin, Q4 FY2025, three months to 2025-01-31. net income / revenueNet income: $26.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-17, accession 0001428336-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $311.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001428336-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure16.3%Net margin, Q1 FY2026, three months to 2025-04-30. net income / revenueNet income: $53.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-28, accession 0001428336-26-000028.Revenue: $330.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-28, accession 0001428336-26-000028.Report this figure18.4%Net margin, Q2 FY2026, three months to 2025-07-31. net income / revenueNet income: $59.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Revenue: $325.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Report this figure16.0%Net margin, Q3 FY2026, three months to 2025-10-31. net income / revenueNet income: $51.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-12-03, accession 0001428336-25-000036.Revenue: $322.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-12-03, accession 0001428336-25-000036.Report this figure14.9%Net margin, Q4 FY2026, three months to 2026-01-31. net income / revenueNet income: $49.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-17, accession 0001428336-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $334.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001428336-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure19.6%Net margin, Q1 FY2027, three months to 2026-04-30. net income / revenueNet income: $69.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-28, accession 0001428336-26-000028.Revenue: $354.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-28, accession 0001428336-26-000028.Report this figure18.7%Net margin, Q2 FY2027, three months to 2026-07-31. net income / revenueNet income: $65.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Revenue: $350.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Report this figure
Diluted EPS$ per share0.06Diluted EPS, Q3 FY2025, three months to 2024-10-31$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-12-03, accession 0001428336-25-000036.Report this figurenot reported (Diluted EPS not reported)0.61Diluted EPS, Q1 FY2026, three months to 2025-04-30$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-28, accession 0001428336-26-000028.Report this figure0.68Diluted EPS, Q2 FY2026, three months to 2025-07-31$0.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Report this figure0.59Diluted EPS, Q3 FY2026, three months to 2025-10-31$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-12-03, accession 0001428336-25-000036.Report this figurenot reported (Diluted EPS not reported)0.82Diluted EPS, Q1 FY2027, three months to 2026-04-30$0.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-28, accession 0001428336-26-000028.Report this figure0.78Diluted EPS, Q2 FY2027, three months to 2026-07-31$0.78 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-27, accession 0001428336-26-000041.Report this figure
Free cash flow$m90.3Free cash flow, Q3 FY2025, three months to 2024-10-31. operating cash flow − capital expenditureOperating cash flow: $90.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-12-03, accession 0001428336-25-000036. Derived: 9-month figure less the 6-month figure.Capital expenditure: $294.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-12-03, accession 0001428336-25-000036. Derived: 9-month figure less the 6-month figure.Report this figure75.4Free cash flow, Q4 FY2025, three months to 2025-01-31. operating cash flow − capital expenditureOperating cash flow: $75.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-17, accession 0001428336-26-000010. Derived: 12-month figure less the 9-month figure.Capital expenditure: $328.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-17, accession 0001428336-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure64.7Free cash flow, Q1 FY2026, three months to 2025-04-30. operating cash flow − capital expenditureOperating cash flow: $64.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-28, accession 0001428336-26-000028.Capital expenditure: $86.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-28, accession 0001428336-26-000028.Report this figure135Free cash flow, Q2 FY2026, three months to 2025-07-31. operating cash flow − capital expenditureOperating cash flow: $135.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-27, accession 0001428336-26-000041. Derived: 6-month figure less the 3-month figure.Capital expenditure: $773.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-27, accession 0001428336-26-000041. Derived: 6-month figure less the 3-month figure.Report this figure138Free cash flow, Q3 FY2026, three months to 2025-10-31. operating cash flow − capital expenditureOperating cash flow: $138.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-12-03, accession 0001428336-25-000036. Derived: 9-month figure less the 6-month figure.Capital expenditure: $784.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-12-03, accession 0001428336-25-000036. Derived: 9-month figure less the 6-month figure.Report this figure118Free cash flow, Q4 FY2026, three months to 2026-01-31. operating cash flow − capital expenditureOperating cash flow: $117.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-17, accession 0001428336-26-000010. Derived: 12-month figure less the 9-month figure.Capital expenditure: $326.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-17, accession 0001428336-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure97.2Free cash flow, Q1 FY2027, three months to 2026-04-30. operating cash flow − capital expenditureOperating cash flow: $97.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-28, accession 0001428336-26-000028.Capital expenditure: $362.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-28, accession 0001428336-26-000028.Report this figure135Free cash flow, Q2 FY2027, three months to 2026-07-31. operating cash flow − capital expenditureOperating cash flow: $136.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-27, accession 0001428336-26-000041. Derived: 6-month figure less the 3-month figure.Capital expenditure: $978.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-27, accession 0001428336-26-000041. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$1.31bnGross margin 69.5%
Diluted EPS$2.46, FY2026
Free cash flow$455.1m, FY2026
Healthequity, Inc., key figures for the last five fiscal years
Line itemUnitFY20222022-01-31FY20232023-01-31FY20242024-01-31FY20252025-01-31FY20262026-01-31Shape over the periods
Revenue$m757Revenue, FY2022, twelve months to 2022-01-31$756.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-22, accession 0001428336-24-000016.Report this figure862Revenue, FY2023, twelve months to 2023-01-31$861.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001428336-25-000009.Report this figure1,000Revenue, FY2024, twelve months to 2024-01-31$999.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001428336-26-000010.Report this figure1,200Revenue, FY2025, twelve months to 2025-01-31$1.20bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001428336-26-000010.Report this figure1,313Revenue, FY2026, twelve months to 2026-01-31$1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001428336-26-000010.Report this figure
Gross margin%56.1%Gross margin, FY2022, twelve months to 2022-01-31. gross profit / revenueGross profit: $424.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-03-22, accession 0001428336-24-000016.Revenue: $756.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-22, accession 0001428336-24-000016.Report this figure57.1%Gross margin, FY2023, twelve months to 2023-01-31. gross profit / revenueGross profit: $491.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-18, accession 0001428336-25-000009.Revenue: $861.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001428336-25-000009.Report this figure62.3%Gross margin, FY2024, twelve months to 2024-01-31. gross profit / revenueGross profit: $622.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-17, accession 0001428336-26-000010.Revenue: $999.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001428336-26-000010.Report this figure64.8%Gross margin, FY2025, twelve months to 2025-01-31. gross profit / revenueGross profit: $777.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-17, accession 0001428336-26-000010.Revenue: $1.20bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001428336-26-000010.Report this figure69.5%Gross margin, FY2026, twelve months to 2026-01-31. gross profit / revenueGross profit: $913.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-17, accession 0001428336-26-000010.Revenue: $1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001428336-26-000010.Report this figure
Operating margin%(3.2%)Operating margin, FY2022, twelve months to 2022-01-31. operating income / revenueOperating income: −$24.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-03-22, accession 0001428336-24-000016.Revenue: $756.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-22, accession 0001428336-24-000016.Report this figure1.1%Operating margin, FY2023, twelve months to 2023-01-31. operating income / revenueOperating income: $9.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-18, accession 0001428336-25-000009.Revenue: $861.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001428336-25-000009.Report this figure11.8%Operating margin, FY2024, twelve months to 2024-01-31. operating income / revenueOperating income: $117.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-17, accession 0001428336-26-000010.Revenue: $999.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001428336-26-000010.Report this figure13.5%Operating margin, FY2025, twelve months to 2025-01-31. operating income / revenueOperating income: $162.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-17, accession 0001428336-26-000010.Revenue: $1.20bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001428336-26-000010.Report this figure24.6%Operating margin, FY2026, twelve months to 2026-01-31. operating income / revenueOperating income: $322.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-17, accession 0001428336-26-000010.Revenue: $1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001428336-26-000010.Report this figure
Net margin%(5.9%)Net margin, FY2022, twelve months to 2022-01-31. net income / revenueNet income: −$44.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-03-22, accession 0001428336-24-000016.Revenue: $756.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-22, accession 0001428336-24-000016.Report this figure(3.0%)Net margin, FY2023, twelve months to 2023-01-31. net income / revenueNet income: −$26.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-18, accession 0001428336-25-000009.Revenue: $861.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001428336-25-000009.Report this figure5.6%Net margin, FY2024, twelve months to 2024-01-31. net income / revenueNet income: $55.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-17, accession 0001428336-26-000010.Revenue: $999.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001428336-26-000010.Report this figure8.1%Net margin, FY2025, twelve months to 2025-01-31. net income / revenueNet income: $96.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-17, accession 0001428336-26-000010.Revenue: $1.20bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001428336-26-000010.Report this figure16.4%Net margin, FY2026, twelve months to 2026-01-31. net income / revenueNet income: $215.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-17, accession 0001428336-26-000010.Revenue: $1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001428336-26-000010.Report this figure
Diluted EPS$ per share(0.53)Diluted EPS, FY2022, twelve months to 2022-01-31−$0.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-03-22, accession 0001428336-24-000016.Report this figure(0.31)Diluted EPS, FY2023, twelve months to 2023-01-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-18, accession 0001428336-25-000009.Report this figure0.64Diluted EPS, FY2024, twelve months to 2024-01-31$0.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-17, accession 0001428336-26-000010.Report this figure1.09Diluted EPS, FY2025, twelve months to 2025-01-31$1.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-17, accession 0001428336-26-000010.Report this figure2.46Diluted EPS, FY2026, twelve months to 2026-01-31$2.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-17, accession 0001428336-26-000010.Report this figure
Free cash flow$m132Free cash flow, FY2022, twelve months to 2022-01-31. operating cash flow − capital expenditureOperating cash flow: $141.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-03-22, accession 0001428336-24-000016.Capital expenditure: $8.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-03-22, accession 0001428336-24-000016.Report this figure147Free cash flow, FY2023, twelve months to 2023-01-31. operating cash flow − capital expenditureOperating cash flow: $150.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-18, accession 0001428336-25-000009.Capital expenditure: $3.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-18, accession 0001428336-25-000009.Report this figure241Free cash flow, FY2024, twelve months to 2024-01-31. operating cash flow − capital expenditureOperating cash flow: $242.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-17, accession 0001428336-26-000010.Capital expenditure: $1.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-17, accession 0001428336-26-000010.Report this figure338Free cash flow, FY2025, twelve months to 2025-01-31. operating cash flow − capital expenditureOperating cash flow: $339.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-17, accession 0001428336-26-000010.Capital expenditure: $2.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-17, accession 0001428336-26-000010.Report this figure455Free cash flow, FY2026, twelve months to 2026-01-31. operating cash flow − capital expenditureOperating cash flow: $457.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-17, accession 0001428336-26-000010.Capital expenditure: $2.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-17, accession 0001428336-26-000010.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Dec 2024 to Nov 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Healthequity, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$1.02bn11,277,914Added+745,520
WASATCH ADVISORS LP2026-06-30$719.0m7,960,735Added+757,801
MORGAN STANLEY2026-06-30$410.7m4,547,219Added+2,061,306
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$366.5m4,057,643Reduced−105,950
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$328.8m3,640,776Reduced−183,028
STATE STREET CORP2026-06-30$292.7m3,241,046Added+141,149
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$214.5m2,374,467Added+114,821
AQR CAPITAL MANAGEMENT LLC2026-06-30$176.1m1,999,209Reduced−93,014
DIMENSIONAL FUND ADVISORS LP2026-06-30$168.8m1,869,036Added+241,997
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC2026-06-30$160.2m1,773,227Added+113,611

Recent filings

All 1,199 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Healthequity, Inc., recent filings
FiledFormWhat it isAccession number
2026-10-0921:00 ET8-K5.02 Departure or appointment of officers or directors0001104659-26-115084
2026-09-3013:02 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure0001428336-26-000045
2026-08-2712:04 ET10-QQuarterly reportPeriod 2026-07-310001428336-26-000041
2026-08-2712:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001428336-26-000040
2026-06-2620:07 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001428336-26-000034
2026-05-2820:04 ET10-QQuarterly reportPeriod 2026-04-300001428336-26-000028
2026-05-2820:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001428336-26-000027
2026-05-1321:25 ETDEF 14AProxy statementPeriod 2026-01-310001428336-26-000022
2026-05-0820:01 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001428336-26-000016
2026-04-0621:01 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001428336-26-000014

Latest annual report

Form 10-K for the fiscal year ended Jan 31, 2026Filed Mar 17, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
1428336
Tickers
HQY
Exchange
Nasdaq
SIC code
7389 Services-Business Services, NEC
Sector
Industrials
Fiscal year ends
Jan 31
Incorporated in
DE
Filer category
Large accelerated filer
Former names
HEALTHEQUITY INC (to 2019-06-06)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.